Pancreatic Cancer News

CD40 Combination Therapy Can Shrink Pancreatic Tumors (April 4, 2019)

A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients – 20 out of 24 as of an interim analysis of the phase 1b trial data. The early findings provide hope that this strategy... Continue Reading

Lynparza Delays Progression of BRCA-mutated Metastatic Pancreatic Cancer (March 18, 2019)

Lynparza (olaparib) improves progression-free survival (PFS) when used to treat BRCA-mutated pancreatic cancer and appears to represent a new treatment option for this hard to treat cancer. (1-4) About BRCA Mutated Pancreatic Cancer Pancreatic cancer... Continue Reading

Lynparza significantly delayed disease progression as 1st-line maintenance treatment in germline BRCA-mutated metastatic pancreatic cancer (February 28, 2019)

Results from the trial showed a significant and clinically-meaningful improvement in progression-free survival (PFS) with Lynparza (olaparib) for the treatment of BRCA-mutated pancreatic cancer. POLO is a randomised, double-blinded, placebo-controlled... Continue Reading

Laurie MacCaskill Partners with CancerConnect (October 19, 2018)

KETCHUM – LOS ANGELES: Laurie MacCaskill, a 12-year survivor of pancreatic cancer and former chair of the Pancreatic Cancer Action Network has announced a newly established partnership with Cancer Connect to support pancreatic cancer patients with information,... Continue Reading

mFOLFIRINOX Found Superior to Gemzar for Treatment Surgically Resected Pancreatic Cancer (June 19, 2018)

The results of a recently presented clinical study at the American Society of Clinical Oncology meetings last week suggest that more aggressive chemotherapy treatment improves outcomes compared to single agent Gemzar (gemcitabine) chemotherapy which has... Continue Reading

First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study (April 18, 2018)

CancerConnect News: The first interim analysis of the SEQUOIA clinical study evaluating the novel immunotherapy drug pegilodecakin in patients with pancreatic cancer will continue to enroll patients based on The Data Monitoring Committee first interim... Continue Reading

Pamrevlumab Awarded “Fast Track” Development Status for Treatment of Patients with Locally Advanced Pancreatic Cancer (March 5, 2018)

CancerConnect News: The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-CTGF antibody, pamrevlumab, for the treatment of patients with locally advanced unresectable pancreatic cancer. This follows review of the... Continue Reading

Larotrectinib Demonstrates 76 Percent Response Rate in TRK Fusion Cancers Including Pancreatic Cancer (February 28, 2018)

CancerConnect News: Clinical data from three ongoing larotrectinib (LOXO-101) clinical trials in patients whose tumors harbor tropomyosin receptor kinase (TRK) fusions demonstrating a 76 percent confirmed objective response rate across tumor types, were... Continue Reading

Diagnosed with Pancreatic Cancer: 10 Tips on How to Get The Most From Your Doctor (December 26, 2017)

1) Choose Your Doctor Carefully Surgeons, medical oncologists and radiation oncologists are the primary doctors involved with pancreatic cancer and often work in collaboration. Pick your primary oncologist carefully, rely on people you trust including... Continue Reading

Clinical Data on Immunotherapy AM0010 in Advanced Pancreatic Cancer Promising (July 11, 2017)

ARMO BioSciences, Inc., a late-stage immuno-oncology company, announced clinical data on its lead investigational immuno-oncology drug AM0010 (pegilodecakin, PEGylated Interleukin-10) at the ESMO 19th World Congress on Gastrointestinal Cancer, taking... Continue Reading

Latest Pancreatic Cancer News By Stage


Recurrent Pancreatic Cancer

Sorry, there are no articles available for this cancer stage.

More Recurrent Pancreatic Cancer

Screening/Prevention Pancreatic Cancer

Sorry, there are no articles available for this cancer stage.

More Screening/Prevention Pancreatic Cancer

Stage IV Pancreatic Cancer

Sorry, there are no articles available for this cancer stage.

More Stage IV Pancreatic Cancer

Stages I-III Pancreatic Cancer

Sorry, there are no articles available for this cancer stage.

More Stages I-III Pancreatic Cancer